Safety of Early Discontinuation of Antiseizure Medication After Acute Symptomatic Neonatal Seizures

IMPORTANCE: Antiseizure medication (ASM) treatment duration for acute symptomatic neonatal seizures is variable. A randomized clinical trial of phenobarbital compared with placebo after resolution of acute symptomatic seizures closed early owing to low enrollment. OBJECTIVE: To assess whether ASM di...

Descripción completa

Detalles Bibliográficos
Autores principales: Glass, Hannah C., Soul, Janet S., Chang, Taeun, Wusthoff, Courtney J., Chu, Catherine J., Massey, Shavonne L., Abend, Nicholas S., Lemmon, Monica, Thomas, Cameron, Numis, Adam L., Guillet, Ronnie, Sturza, Julie, McNamara, Nancy A., Rogers, Elizabeth E., Franck, Linda S., McCulloch, Charles E., Shellhaas, Renée A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145161/
https://www.ncbi.nlm.nih.gov/pubmed/34028496
http://dx.doi.org/10.1001/jamaneurol.2021.1437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145161/
https://www.ncbi.nlm.nih.gov/pubmed/34028496
http://dx.doi.org/10.1001/jamaneurol.2021.1437

Ejemplares similares